Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Lee JW, Han JK, Kim TK, Choi BI, Park SH, Ko YH, Yoon CJ, Yeon KM. Obstructive jaundice in hepatocellular carcinoma: response after percutaneous transhepatic biliary drainage and prognostic factors. Cardiovasc Intervent Radiol 2002. [PMID: 12058212 DOI: 10.1007/s00270-0010100-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]

For:	Lee JW, Han JK, Kim TK, Choi BI, Park SH, Ko YH, Yoon CJ, Yeon KM. Obstructive jaundice in hepatocellular carcinoma: response after percutaneous transhepatic biliary drainage and prognostic factors. Cardiovasc Intervent Radiol 2002. [PMID: 12058212 DOI: 10.1007/s00270-0010100-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]

Number	Cited by Other Article(s)
1	Sugiyama G, Okabe Y, Ishida Y, Saitou F, Kawahara R, Ishikawa H, Horiuchi H, Kinoshita H, Tsuruta O, Sata M. Evaluation of endoscopic biliary stenting for obstructive jaundice caused by hepatocellular carcinoma. World J Gastroenterol 2014;20:6968-6973. [PMID: 24944490 PMCID: PMC4051939 DOI: 10.3748/wjg.v20.i22.6968] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/21/2013] [Accepted: 02/20/2014] [Indexed: 02/06/2023] Open Abstract AIM: To review the usefulness of endoscopic biliary stenting for obstructive jaundice caused by hepatocellular carcinoma and identify problems that may need to be addressed. METHODS: The study population consisted of 36 patients with obstructive jaundice caused by hepatocellular carcinoma (HCC) who underwent endoscopic biliary stenting (EBS) as the initial drainage procedure at our hospital. The EBS technical success rate and drainage success rate were assessed. Drainage was considered effective when the serum total bilirubin level decreased by 50% or more following the procedure compared to the pre-drainage value. Survival time after the procedure and patient background characteristics were assessed comparatively between the successful drainage group (group A) and the non-successful drainage group (group B). The EBS stent patency duration in the successful drainage group (group A) was also assessed. RESULTS: The technical success rate was 100% for both the initial endoscopic nasobiliary drainage and EBS in all patients. Single stenting was placed in 21 patients and multiple stenting in the remaining 15 patients. The drainage successful rate was 75% and the median interval to successful drainage was 40 d (2-295 d). The median survival time was 150 d in group A and 22 d in group B, with the difference between the two groups being statistically significant (P < 0.0001). There were no statistically significant differences between the two groups with respect to patient background characteristics, background liver condition, or tumor factors; on the other hand, the two groups showed statistically significant differences in patients without a history of hepatectomy (P = 0.009) and those that received multiple stenting (P = 0.036). The median duration of stent patency was 43 d in group A (2-757 d). No early complications related to the EBS technique were encountered. Late complications occurred in 13 patients (36.1%), including stent occlusion in 7, infection in 3, and distal migration in 3. CONCLUSION: EBS is recommended as the initial drainage procedure for obstructive jaundice caused by HCC, as it appears to contribute to prolongation of survival time. Collapse Key Words Hepatocellular carcinoma Obstructive jaundice Biliary drainage Percutaneous transhepatic biliary drainage Endoscopic biliary stenting Collapse MESH Headings Adult Aged Bilirubin/blood Biomarkers/blood Carcinoma, Hepatocellular/complications Carcinoma, Hepatocellular/mortality Cholangiopancreatography, Endoscopic Retrograde/adverse effects Cholangiopancreatography, Endoscopic Retrograde/instrumentation Cholangiopancreatography, Endoscopic Retrograde/mortality Drainage/adverse effects Drainage/instrumentation Drainage/mortality Female Humans Jaundice, Obstructive/blood Jaundice, Obstructive/diagnosis Jaundice, Obstructive/etiology Jaundice, Obstructive/mortality Jaundice, Obstructive/therapy Kaplan-Meier Estimate Liver Neoplasms/complications Liver Neoplasms/mortality Male Middle Aged Palliative Care Retrospective Studies Risk Factors Stents Time Factors Treatment Outcome Collapse Grants Collapse Affiliation(s) Collapse Collaborators Collapse

Number

Cited by Other Article(s)

Sugiyama G, Okabe Y, Ishida Y, Saitou F, Kawahara R, Ishikawa H, Horiuchi H, Kinoshita H, Tsuruta O, Sata M. Evaluation of endoscopic biliary stenting for obstructive jaundice caused by hepatocellular carcinoma. World J Gastroenterol 2014;20:6968-6973. [PMID: 24944490 PMCID: PMC4051939 DOI: 10.3748/wjg.v20.i22.6968] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/21/2013] [Accepted: 02/20/2014] [Indexed: 02/06/2023] Open

Abstract

AIM: To review the usefulness of endoscopic biliary stenting for obstructive jaundice caused by hepatocellular carcinoma and identify problems that may need to be addressed.

METHODS: The study population consisted of 36 patients with obstructive jaundice caused by hepatocellular carcinoma (HCC) who underwent endoscopic biliary stenting (EBS) as the initial drainage procedure at our hospital. The EBS technical success rate and drainage success rate were assessed. Drainage was considered effective when the serum total bilirubin level decreased by 50% or more following the procedure compared to the pre-drainage value. Survival time after the procedure and patient background characteristics were assessed comparatively between the successful drainage group (group A) and the non-successful drainage group (group B). The EBS stent patency duration in the successful drainage group (group A) was also assessed.

RESULTS: The technical success rate was 100% for both the initial endoscopic nasobiliary drainage and EBS in all patients. Single stenting was placed in 21 patients and multiple stenting in the remaining 15 patients. The drainage successful rate was 75% and the median interval to successful drainage was 40 d (2-295 d). The median survival time was 150 d in group A and 22 d in group B, with the difference between the two groups being statistically significant (P < 0.0001). There were no statistically significant differences between the two groups with respect to patient background characteristics, background liver condition, or tumor factors; on the other hand, the two groups showed statistically significant differences in patients without a history of hepatectomy (P = 0.009) and those that received multiple stenting (P = 0.036). The median duration of stent patency was 43 d in group A (2-757 d). No early complications related to the EBS technique were encountered. Late complications occurred in 13 patients (36.1%), including stent occlusion in 7, infection in 3, and distal migration in 3.

CONCLUSION: EBS is recommended as the initial drainage procedure for obstructive jaundice caused by HCC, as it appears to contribute to prolongation of survival time.

Collapse